Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05701254

Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk

Status
Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Creighton University · Academic / Other
Sex
Female
Age
50 Years
Healthy volunteers
Accepted

Summary

Patients with Type 1 Diabetes Mellitus (T1DM) have a higher risk of low-trauma (osteoporotic) fracture that is 7-12 times higher than non-diabetics. The bone density of people with Type 1 Diabetes is higher at the time of fracture than in non-diabetics. This suggests the presence of underlying bone tissue mechanical defects. The potential benefits to participants would be knowledge gained about their bone density and the results of laboratory tests. On a wider scale, there may be general benefits to society because the knowledge gained from this study may help better understand the effects of diabetes on bone health

Detailed description

The investigators will enroll 40 female, postmenopausal, patients with T1DM, fracturing or non-fracturing, who are age 50 and over, and have had diabetes for more than ten years. The investigators will perform 2 transiliac (hip bone) biopsies on each subject, one for mechanical testing, tissue analysis of AGEs, enzymatic crosslinks and bone tissue-bound water in cortical bone, and the other for histomorphometry and high-resolution 3D imaging in trabecular bone. A matched, non-diabetic, healthy control will be enrolled at the time each T1DM is enrolled.

Conditions

Interventions

TypeNameDescription
PROCEDURETransilial bone biopsyThe transiliac bone biopsy will be performed on each subject under local anesthesia, and conscious sedation. From one skin incision located \~2cm posterior and inferior to the anterior-superior pelvic spine on one side of the pelvis, the investigators will obtain two iliac bone specimens, each 7.5 mm in diameter, cylindrical in shape, and including both inner and outer cortices and the intervening trabecular bone.

Timeline

Start date
2019-06-18
Primary completion
2024-12-01
Completion
2025-01-01
First posted
2023-01-27
Last updated
2024-09-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05701254. Inclusion in this directory is not an endorsement.